Concepedia

H. M. Faessel

HM

3

Publications

143

Citations

3

H-Index

2002

Active since

Affiliations

Pfizer (United States)(Current)

H. M. Faessel is an author at Pfizer (United States) specializing in neuropharmacology, tobacco cessation, and pharmacotherapy.

Top concepts

Publications per year

2002–2008

3

Publications

3

Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study

Bo Feng, RS Obach, AH Burstein et al. · Clinical Pharmacology & Therapeutics · 2007 · 83 citations

Ranitidine, 75 mg, over‐the‐counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro‐oesophageal reflux

Susan R. Orenstein, Jeffrey L. Blumer, H. M. Faessel et al. · Alimentary Pharmacology & Therapeutics · 2002 · 41 citations · Full text

Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers

H. M. Faessel, Aaron H. Burstein, Matthew D. Troutman et al. · European Journal of Clinical Pharmacology · 2008 · 19 citations

, , +8

Rows per page

1–3 of 3